Search Results - "Chábová, V"

Refine Results
  1. 1

    The dilemma of dual renin-angiotensin system blockade in chronic kidney disease: why beneficial in animal experiments but not in the clinic? by Čertíková Chábová, V, Červenka, L

    Published in Physiological research (01-01-2017)
    “…Drugs interfering with the renin-angiotensin-aldosterone system (RAAS) improved the prognosis in patients with hypertension, heart failure, diabetes and…”
    Get full text
    Journal Article
  2. 2

    Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats by Vanecková, I, Skaroupková, P, Dvorák, P, Certíková Chábová, V, Tesar, V, Bader, M, Ganten, D, Kramer, H J

    Published in Physiological research (2005)
    “…The present study was performed to evaluate the effects of sodium intake and of chronic cyclooxygenase-2 (COX-2) inhibition on systolic blood pressure (SBP) in…”
    Get full text
    Journal Article
  3. 3

    Recent insights into the pathogenesis of nephrotic syndrome by Certikova-Chabova, V, Tesar, V

    Published in Minerva medica (01-06-2013)
    “…Nephrotic syndrome is characterized by heavy proteinuria followed by hypoproteinemia, hypercholestrolemia, lipiduria, and edema. The glomerular filtration…”
    Get more information
    Journal Article
  4. 4

    Outcomes of atherosclerotic renal artery stenosis managed without revascularization by Chábová, V, Schirger, A, Stanson, A W, McKusick, M A, Textor, S C

    Published in Mayo Clinic proceedings (01-05-2000)
    “…To determine how often patients with renal artery stenosis (RAS) managed without revascularization progress to accelerated hypertension and/or renal failure…”
    Get more information
    Journal Article
  5. 5

    The role of arachidonic acid metabolites in the regulation of renal function and pathogenesis of hypertension by Certíková Chábová, V

    Published in Československa fyziologie (2008)
    “…Eicosanoids are twenty-carbon compounds derived from arachidonic acid. Lipoxygenases, cyclooxygenases and cytochrome P-450 enzymes contribute to their…”
    Get more information
    Journal Article
  6. 6

    Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange by Tesar, V, Jelínková, E, Jirsa, Jr, M, Bakosová, M, Pitha, P, Chábová, V

    Published in Blood purification (01-01-2000)
    “…Plasma exchange (PE) is an effective therapeutic method used in patients with myasthenia gravis (MG) refractory to common therapy and/or with life-threatening…”
    Get more information
    Journal Article
  7. 7

    Pathophysiology of diabetic nephropathy by Chábová, V

    Published in Časopis lékařů českých (28-06-1999)
    “…The epidemic increase of diabetic nephropathy stimulated also the interest in pathophysiological mechanisms that lead to the development of the disease. The…”
    Get more information
    Journal Article
  8. 8

    Diabetic nephropathy by Chábová, V

    Published in Časopis lékařů českých (19-11-1997)
    “…Diabetic nephropathy is one of the microvascular complications of diabetes. Its incidence is decreasing in insulin dependent patients, but extremely increasing…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Long term treatment of IgA nephropathy with cyclosporine A by Chábová, V, Tesar, V, Zabka, J, Rychlik, I, Merta, M, Jirsa, Jr, M, Stejskalová, A

    Published in Renal failure (01-01-2000)
    “…20-50% of patients with IgA nephropathy (IgAN) reach end-stage renal failure. Yet a standard treatment for those with progressive course and/or great…”
    Get more information
    Journal Article
  12. 12

    Relation between plasma levels of IGF-I, leptin and TNF-alpha in diabetics by Chábová, V, Perusicová, J, Tesar, V, Zabka, J, Merta, M, Rychlík, T, Zima, T, Bradová, V

    Published in Časopis lékařů českých (29-03-1999)
    “…TNF-alpha, IGF-I and leptin are agents which influence insulin resistance, they play probably a part in the pathogenesis of diabetic nephropathy and influence…”
    Get more information
    Journal Article
  13. 13

    Thromboembolic complications in nephrotic syndrome by Zima, T, Chábová, V, Tesar, V, Gorican, K

    Published in Časopis lékařů českých (21-08-1996)
    “…Thromboembolic complications of nephrotic syndrome are very frequent. They can occur in the arterial or venous circulation. Venous thromboses are frequently…”
    Get more information
    Journal Article
  14. 14

    Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis by Tesar, V, Jelínková, E, Jirsa, Jr, M, Bakosová, N, Pit'ha, V, Chábová, V

    Published in Časopis lékařů českých (02-11-1998)
    “…Plasma exchange (PE) is effective therapeutic method used in patients with myasthenia gravis (MG) refractory to common therapy and/or with life-threatening…”
    Get more information
    Journal Article
  15. 15

    Plasma leptin levels in patients with kidney diseases of various etiologies by Chábová, V, Tesar, V, Perusicová, J, Zima, T, Zabka, J, Rychlík, I, Merta, M, Bradová, V, Stípek, S

    Published in Časopis lékařů českých (02-08-1999)
    “…Leptin is a new hormone influencing food intake, energy expenditure and body weight. This protein is produced by adipocytes, exerts its effects on brain,…”
    Get more information
    Journal Article
  16. 16

    Clinical spectrum of the antiphospholipid syndrome by Chábová, V, Tesar, V, Zabka, J, Bartůnková, J, Stejskalová, A, Dostál, C, Valenta, J, Rychlík, I

    Published in Časopis lékařů českých (16-04-1997)
    “…Antiphospholipid syndrome (APS) is characterized by multiple arterial and venous thromboses, repeated spontaneous abortions and thrombocytopenia, together with…”
    Get more information
    Journal Article
  17. 17

    Long-term administration of cyclosporine A in patients with IgA nephropathy by Chábová, V, Tesar, V, Zabka, J, Rychlík, I, Merta, M, Jirsa, M, Stejskalová, A, Stejskal, J

    Published in Časopis lékařů českých (18-12-1996)
    “…IgA nephropathy is the most common glomerulonephritis all over the world and a considerable proportion of the patients reaches end-stage renal failure. Yet the…”
    Get more information
    Journal Article
  18. 18

    Rhabdomyolysis and acute renal failure by Chábová, V, Tesar, V, Lachmanová, J, Zima, T

    Published in Časopis lékařů českých (06-12-1993)
    “…Rhabdomyolysis is damage of the skeletal muscles due to different causes which leads to the release of the contents of muscle cells into the blood stream and…”
    Get more information
    Journal Article
  19. 19

    Acute kidney failure associated with rhabdomyolysis by Chábová, V, Tesar, V, Lachmanová, J, Zima, T

    Published in Časopis lékařů českých (06-12-1993)
    “…The authors describe three cases of rhabdomyolysis and acute renal failure. In all patients rhabdomyolysis developed in conjunction with ingestion of alcohol,…”
    Get more information
    Journal Article
  20. 20

    Soluble cytokinin receptors in renal vasculitis and lupus nephritis by Tesar, V, Jirsa, Jr, M, Masek, Z, Bartůnková, J, Stejskalová, A, Dostál, C, Zabka, J, Chábová, V, Rysavá, R

    Published in Časopis lékařů českých (04-05-1998)
    “…Activation of various cytokines, e.g. TNF alpha, IL-1 and/or IL-6 may play important role in the pathogenesis of renal vasculitis and lupus nephritis (LN)…”
    Get more information
    Journal Article